In May of 1957, life magazine published an article called "seeking the magic mushroom."  It's the story of two amateur mycologists who traveled to the remote mountains of mexico in search of psilocybin mushrooms.  The article changed the mental health landscape forever.  These two scientists became the first westerners to experience the Mazatec sacred psilocybin mushroom ritual...and the term "magic mushrooms" went mainstream.  Soon after in 1958. Swiss chemist Albert Hofman made one of the most important molecular discoveries of the last century.  Hofman was the first to identify the compounds psilocybin and psilocin...and how they transform inside the human body.    Fast forward past the psychedelic 60's...andpast the war on drugs of the 70's when psychedelics were made illegal...all the way to the year 2006.  This is when researchers at John Hopkins University published a landmark study on the life-changing effects of a single dose of psilocybin.  Just like that...a new industry was born.  Psilocybin and other psychedelic medicines were back on the map.  Today, thanks to new brain models and fMRI brain imaging technology...scientists believe that these molecules may be as close to a "brain reset" button as we could find.    The medical mushroom market is a 13 billion dollar market.  Also the demand for telepsychiatry services is a 5.5 billion dollar marker with untapped potential...And it's growing fast.  Many of the traditional synthetic drugs are outdated and ineffective.  Their side effects are potentially dangerous.  Those dealing with mental health issues deserve better.  The mental health paradigm is shifting to psychedelic medicine.  Researchers are finding that a single dose of psilocybin can enhance creative thinking, empathy, and well being in healthy adults.  There are currently 43 different clinical trials in various stages of progress.  Researchers are further exploring how psychedelic medicine can potentially help patients with depression, PTSD, anxiety, alcohol addiction and opioid use disorder.    Timothy Furnish, MD, from the UC San Diego School of Medicine is one of the lead researchers.  "Psilocybin has the potential to 'reset' altered cortical brain circuits associated with certain chronic pain conditions.  We have already seen the evidence that psilocybin may reset these circuits."  The future of psychedelic medicine is synergistic-not synthetic.